{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:52:52Z","timestamp":1791622372833,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T00:00:00Z","timestamp":1373587200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-317","type":"journal-article","created":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T20:14:04Z","timestamp":1373660044000},"source":"Crossref","is-referenced-by-count":27,"title":["Infections in patients taking Rituximab for hematologic malignancies: two-year cohort study"],"prefix":"10.1186","volume":"13","author":[{"given":"Simone","family":"Lanini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife C","family":"Molloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archibald G","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C","family":"Kibbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,12]]},"reference":[{"issue":"1","key":"2521_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/rheumatology\/kel148","volume":"46","author":"MJ Leandro","year":"2007","unstructured":"Leandro MJ, Cooper N, Cambridge G, Ehrenstein MR, Edwards JC: Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy. Rheumatology (Oxford). 2007, 46 (1): 29-36. 10.1093\/rheumatology\/kel148.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"2521_CR2","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1080\/10428190701644330","volume":"48","author":"R Baz","year":"2007","unstructured":"Baz R, Fanning S, Kunkel L, Gaballa S, Karam MA, Reed J, Kelly M, Hussein M: Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple myeloma. Leuk Lymphoma. 2007, 48 (12): 2338-44. 10.1080\/10428190701644330.","journal-title":"Leuk Lymphoma"},{"key":"2521_CR3","first-page":"CD003805","volume":"4","author":"H Schulz","year":"2007","unstructured":"Schulz H, Bohlius J, Skoetz N, Trelle S, Kober T, Reiser M, Dreyling M, Herold M, Schwarzer G, Hallek M, Engert A: Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma. Cochrane Db Syst Rev. 2007, 4: CD003805-","journal-title":"Cochrane Db Syst Rev"},{"key":"2521_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1741-7015-9-36","volume":"9","author":"S Lanini","year":"2011","unstructured":"Lanini S, Molloy AC, Fine PE, Prentice AG, Ippolito G, Kibbler CC: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis. BMC Med. 2011, 9: 36-10.1186\/1741-7015-9-36.","journal-title":"BMC Med"},{"key":"2521_CR5","unstructured":"European Medicines Agency (EMEA): MabThera EMEA\/H\/C\/000165 -II\/0070\/G 20\/12\/2010 available at \n                    http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000165\/human_med_000897.jsp&murl=menus\/medicines\/medicines.jsp&mid=WC0b01ac058001d125"},{"issue":"1","key":"2521_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","volume":"17","author":"D Wolff","year":"2011","unstructured":"Wolff D, Schleuning M, Von Harsdorf S, Bacher U, Gerbitz A, Stadler M, Ayuk F, Kiani A, Schwerdtfeger R, Vogelsang GB, Kobbe G, Gramatzki M, Lawitschka A, Mohty M, Pavletic SZ, Greinix H, Holler E: Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2011, 17 (1): 1-17. 10.1016\/j.bbmt.2010.05.011.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2521_CR7","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1182\/blood-2006-01-0233","volume":"108","author":"C Cutler","year":"2006","unstructured":"Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D, Klickstein LB, Levin J, Miller K, Reynolds C, Macdonell R, Pasek M, Lee SJ, Ho V, Soiffer R, Antin JH, Ritz J, Alyea E: Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006, 108 (2): 756-62. 10.1182\/blood-2006-01-0233.","journal-title":"Blood"},{"issue":"2","key":"2521_CR8","first-page":"CD008794","volume":"16","author":"JA Singh","year":"2011","unstructured":"Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R: Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Db Syst Rev. 2011, 16 (2): CD008794-","journal-title":"Cochrane Db Syst Rev"},{"key":"2521_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/jnci\/djn478","volume":"101","author":"L Vidal","year":"2009","unstructured":"Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials. J Natl Cancer Inst. 2009, 101: 248-255. 10.1093\/jnci\/djn478.","journal-title":"J Natl Cancer Inst"},{"key":"2521_CR10","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","volume":"106","author":"LD Kaplan","year":"2005","unstructured":"Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT: Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood. 2005, 106: 1538-1543. 10.1182\/blood-2005-04-1437.","journal-title":"Blood"},{"issue":"10","key":"2521_CR11","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, Von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M: STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007, 4 (10): e297-10.1371\/journal.pmed.0040297.","journal-title":"PLoS Med"},{"issue":"1","key":"2521_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0895-4356(99)00137-7","volume":"53","author":"T St\u00fcrmer","year":"2000","unstructured":"St\u00fcrmer T, Glynn RJ, Kliebsch U, Brenner H: Analytic strategies for recurrent events in epidemiologic studies: background and application to hospitalization risk in the elderly. J Clin Epidemiol. 2000, 53 (1): 57-64. 10.1016\/S0895-4356(99)00137-7.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2521_CR13","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.ijid.2010.03.025","volume":"15","author":"T Kelesidis","year":"2011","unstructured":"Kelesidis T, Daikos G, Boumpas D, Tsiodras S: Does rituximab increase the incidence of infectious complications? A narrative review. Int J Infect Dis. 2011, 15 (1): e2-16. 10.1016\/j.ijid.2010.03.025.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"2521_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bmt.1702822","volume":"27","author":"G Reich","year":"2001","unstructured":"Reich G, Mapara MY, Reichardt P, D\u00f6rken B, Maschmeyer G: Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow Transplant. 2001, 27 (5): 525-9. 10.1038\/sj.bmt.1702822.","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2521_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1532\/IJH97.E0633","volume":"86","author":"N Puig","year":"2007","unstructured":"Puig N, De la Rubia J, Jarque I, Salavert M, Montesinos P, Sanz J, Mart\u00edn G, Sanz G, Cantero S, Lorenzo I, Sanz MA: A study of incidence and characteristics of infections in 476 patients from a single center undergoing autologous blood stem cell transplantation. Int J Hematol. 2007, 86 (2): 186-92. 10.1532\/IJH97.E0633.","journal-title":"Int J Hematol"},{"issue":"1","key":"2521_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00520-005-0836-1","volume":"14","author":"GS Guven","year":"2006","unstructured":"Guven GS, Uzun O, Cakir B, Akova M, Unal S: Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997\u20132001). Support Care Cancer. 2006, 14 (1): 52-5. 10.1007\/s00520-005-0836-1.","journal-title":"Support Care Cancer"},{"key":"2521_CR17","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/10428190701411441","volume":"48","author":"S Aksoy","year":"2007","unstructured":"Aksoy S, Harputluoglu H, Kilickap S, Dede DS, Dizdar O, Altundag K, Barista I: Rituximab-related viral infections in lymphoma patients. Leuk Lymphoma. 2007, 48: 1307-1312. 10.1080\/10428190701411441.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"2521_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD: Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol. 2010, 10 (4): 236-47. 10.1038\/nri2729.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2521_CR19","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1038\/jid.2008.172","volume":"128","author":"R Eming","year":"2008","unstructured":"Eming R, Nagel A, Wolff-Franke S, Podstawa E, Debus D, Hertl M: Rituximab exerts a dual effect in pemphigus vulgaris. J Invest Dermatol. 2008, 128 (12): 2850-8. 10.1038\/jid.2008.172.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"2521_CR20","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1182\/blood-2007-02-068999","volume":"110","author":"R Stasi","year":"2007","unstructured":"Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N, Amadori S: Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood. 2007, 110 (8): 2924-30. 10.1182\/blood-2007-02-068999.","journal-title":"Blood"},{"issue":"1","key":"2521_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.clim.2006.08.016","volume":"122","author":"T Vallerskog","year":"2007","unstructured":"Vallerskog T, Gunnarsson I, Widhe M, Risselada A, Klareskog L, Van Vollenhoven R, Malmstr\u00f6m V, Trollmo C: Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol. 2007, 122 (1): 62-74. 10.1016\/j.clim.2006.08.016.","journal-title":"Clin Immunol"},{"issue":"11","key":"2521_CR22","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1182\/blood-2007-11-122713","volume":"111","author":"D Saadoun","year":"2008","unstructured":"Saadoun D, Rosenzwajg M, Landau D, Piette JC, Klatzmann D, Cacoub P: Restoration of peripheral immune homeostasis after rituximab in mixed cryoglobulinemia vasculitis. Blood. 2008, 111 (11): 5334-41. 10.1182\/blood-2007-11-122713.","journal-title":"Blood"},{"issue":"4","key":"2521_CR23","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.4049\/jimmunol.0802501","volume":"182","author":"JK Whitmire","year":"2009","unstructured":"Whitmire JK, Asano MS, Kaech SM, Sarkar S, Hannum LG, Shlomchik MJ, Ahmed R: Requirement of B cells for generating CD4+ T cell memory. J Immunol. 2009, 182 (4): 1868-76. 10.4049\/jimmunol.0802501.","journal-title":"J Immunol"},{"issue":"13","key":"2521_CR24","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1084\/jem.20082039","volume":"205","author":"N Iijima","year":"2008","unstructured":"Iijima N, Linehan MM, Zamora M, Butkus D, Dunn R, Kehry MR, Laufer TM, Iwasaki A: Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus. J Exp Med. 2008, 205 (13): 3041-52. 10.1084\/jem.20082039.","journal-title":"J Exp Med"},{"key":"2521_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/02841860903150502","volume":"49","author":"G Gao","year":"2010","unstructured":"Gao G, Liang X, Jiang J, Zhou X, Huang R, Chu Z, Zhan Q, 1: A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma. Acta Oncol. 2010, 49: 3-12. 10.3109\/02841860903150502.","journal-title":"Acta Oncol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-317\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-317.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T07:19:35Z","timestamp":1548227975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2521"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-317","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,12]]},"article-number":"317"}}